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in Early Middle-Age Adults Based on the
10-Year Framingham Risk Score
The CARDIA Study
Tochi M. Okwuosa, DO,* Philip Greenland, MD,† Hongyan Ning, MD, MS,†
Kiang Liu, PHD,† Donald M. Lloyd-Jones, MD, SCM†
Detroit, Michigan; and Chicago, Illinois
O B J E C T I V E S The purpose of this study was to assess the prevalence and distribution of coronary
artery calcium (CAC) across Framingham Risk Score (FRS) strata and therefore determine FRS levels at which
asymptomatic, young to early middle-age individuals could potentially beneﬁt from CAC screening.
B A C KG ROUND High CAC burden is associated with increased risk of coronary events beyond the
FRS. Expert panel recommendations for CAC screening are based on data obtained in middle-age and
older individuals.
METHOD S We included 2,831 CARDIA (Coronary Artery Risk Development in Young Adults) study
participants with an age range of 33 to 45 years. The number needed to screen ([NNS] number of people
in each FRS stratum who need to be screened to detect 1 person with a CAC score above the speciﬁed
cut point) was used to assess the yield of screening for CAC. CAC prevalence was compared across FRS
strata using a chi-square test.
R E S U L T S CAC scores0 and100 were present in 9.9% and 1.8% of participants, respectively. CAC
prevalence and amount increased across higher FRS strata. A CAC score0 was observed in 7.3%, 20.2%,
19.1%, and 44.8% of individuals with FRSs of 0 to 2.5%, 2.6% to 5%, 5.1% to 10%, and10%, respectively
(NNS 14, 5, 5, and 2, respectively). A CAC score of100 was observed in 1.3%, 2.4%, and 3.5% of those
with FRSs of 0 to 2.5%, 2.6% to 5%, and 5.1% to 10%, respectively (NNS  79, 41, and 29, respectively),
but in 17.2% of those with an FRS 10% (NNS  6). Similar trends were observed when ﬁndings were
stratiﬁed by sex and race.
CONC L U S I O N S In this young to early middle-age cohort, we observed concordance between
CAC prevalence/amount and FRS strata. Within this group, the yield of screening and possibility of
identifying those with a high CAC burden (CAC score of 100) is low in those with an FRS of 10%, but
considerable in those with an FRS 10%. (J Am Coll Cardiol Img 2012;5:923–30) © 2012 by the
American College of Cardiology Foundation
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924AC is associated with an increased risk of
coronary heart disease (CHD) events and
provides incremental risk prediction be-
yond the Framingham Risk Score (FRS)
1). Coronary artery calcium (CAC) increases with
ge and is associated with traditional risk factor
urden. In addition, higher CAC burden (CAC
core 100) carries a greater risk of CHD events
1), and compared with traditional cardiovascular
isk factors alone, CAC scoring improves risk clas-
ification for the prediction of CHD events (2).
See page 931
To date, some expert panels have recommended
testing for CAC in intermediate-risk individuals
(FRS predicted 10-year risk 10% to 20%) (1,3) and
state that although it could be reasonable to screen
for CAC in low- to intermediate-risk (FRS 6% to
10%) individuals, it is reasonable to do so in those
at intermediate risk (FRS 10% to 20%) (4). Others
suggest that there is more harm than benefit result-
ing from CAC measurement in intermediate-
risk individuals (5), and yet other panels
suggest a benefit of widespread CAC
screening in all asymptomatic men 45 to
75 years of age and asymptomatic women
55 to 75 years of age, except for those
defined as very low risk based on the
absence of any traditional cardiovascular
risk factors (6). With the exception of a
tudy by Taylor et al. (7), most of the studies cited
y these consensus panels examining associations
etween CAC and CHD events included partici-
ants with mean ages older than 50 years, likely
ecause of lower power to detect CHD events in
he younger population. Thus, expert recommenda-
ions are even less clear about screening for CAC in
he younger population even though this population
s still at risk of the development of CAC and CHD
vents (7).
We previously observed, based on the distribu-
ion of CAC relative to FRS, in the Multi-Ethnic
tudy of Atherosclerosis cohort (mean age, 60.9
ears), that there might be minimal benefit to
creening for clinically significant levels of CAC in
ery low risk persons with an FRS of 5% (8).
owever, for young and early middle-age persons, an
ppropriate FRS threshold above which CAC screen-
ng might be useful is unclear. Although some studies
xamined the relationship between CAC distribution
nd FRS (9–15), none were performed in individuals
m
se
re
reenounger than 50 years of age. tIn the younger to early middle-age asymptomatic
iracial cohort of the CARDIA (Coronary Artery
isk Development in Young Adults) study, we
ought to ascertain the prevalence and distribution
f CAC across Framingham risk categories, strati-
ed by sex and race. These associations can then
orm the basis for determining the yield of CAC
creening, and therefore the FRS ranges for which
AC scoring might be beneficial in risk assessment.
indings from this study may facilitate further risk
tratification for young, asymptomatic individuals
redicted to be at low or intermediate 10-year risk
y age and traditional risk factors.
M E T H O D S
The CARDIA study is a multicenter, prospective
cohort study designed to investigate the evolution
of CHD risk in young adults. Details of the study
design, as well as inclusion/exclusion criteria and
baseline characteristics, were described previously
(16). Briefly, the CARDIA study enrolled 5,115 black
and white participants (55% women), ranging from 18
to 30 years of age, during the period 1985 to 1986
from 4 U.S. urban areas (Birmingham, Alabama;
Oakland, California; Chicago, Illinois; and Minneap-
olis, Minnesota). The institutional review boards at all
the study sites approved the study protocol, and
written informed consent was obtained from all study
participants. The study was designed to include ap-
proximately balanced numbers of participants by age,
sex, race, and education level.
For the current study, we included men and women
with measured coronary calcium at the year 15 (our
study baseline) examination (n  3,043), when the
mean age was approximately 40 years. From this
number, we excluded 170 participants with diabetes
because they are considered high-risk under current
National Cholesterol Education Program Adult
Treatment Panel III guidelines (17), and we focused
on evaluating the yield of screening in individuals at
lower risk. Additionally, 41 participants were excluded
due to missing FRS equation covariates.
Risk factor measurements. Data on cigarette smok-
ng status, age, race, socioeconomic measures, dia-
etes history, and medication use were obtained by
articipant self-report (16). Current smoking was
efined as at least 5 cigarettes per week almost every
eek for at least 3 months. Family history of
yocardial infarction was obtained using a self-
dministered questionnaire. Blood pressure was
easured 3 times with a random-zero device, andA B B R E V I A T I O N S
A N D A C R O N YM S
CAC coronary artery calciu
CHD coronary heart disea
FRS Framingham Risk Scohe average of the last 2 measurements was used.
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925Body mass index was calculated by dividing weight
in kilograms by the square of the height in meters.
The CARDIA study physical activity history ques-
tionnaire was used to assess physical activity, which
was coded as exercise units (18). Venous blood
samples were obtained from participants after a
12-h fast. Plasma triglycerides and total and high-
density lipoprotein cholesterol were determined
using an enzymatic assay by Northwest Lipids
Research Laboratory (Seattle, Washington). Low-
density lipoprotein cholesterol was then derived
using the Friedewald equation (19).
Agatston CAC measurement and scoring were
previously described (20). The presence of CAC
was defined as having a positive, nonzero Agatston
score determined from the average of 2 scans.
Because of the young age of the participants, each
scan set with at least 1 nonzero score was reviewed
and verified by an expert investigator who was
blinded to the scan scores. There was reasonable
agreement between scans (kappa  0.79, with only
3.6% discordance). For this study, CAC scores were
categorized as 0 or 100. The prevalence of
advanced CAC (CAC score 300 or 400) was too
low in this cohort because of the younger age of the
participants. As such, we made use of a lower cut
point (CAC score 100, previously shown to be
associated with increased risk of CHD events) (1)
in our definition of high CAC burden. Concurrent
FRS 10-year risk of CHD was calculated and
stratified as follows: 0 to 2.5%, 2.6% to 5%, 5.1% to
10%, and 10%. Further stratification of FRS
categories for those with an FRS 10% would not
have been meaningful due to the relative youth and
therefore low-risk composition of our study cohort.
Statistical analysis. All analyses were performed us-
ng SAS software, version 9.2 (SAS Institute, Cary,
orth Carolina). A 2-tailed p value 0.05 was
onsidered statistically significant. The Framing-
am 10-year risk estimates for all participants were
alculated using the risk prediction functions from
he National Cholesterol Education Program Adult
reatment Panel III guidelines (17) based on an
pdate from the Framingham methodology re-
orted by Wilson et al. (21). The covariates in-
luded in the FRS calculation were age, total and
igh-density lipoprotein cholesterol levels, current
moking status, systolic blood pressure, and the use
f antihypertensive medication. Baseline character-
stics were compared according to FRS 10-year risk
trata and by CAC categories using general linear
odels for continuous variables and cross-abulations for categorical variables. A chi-square iest was used to compare the prevalence of CAC
ategories across FRS 10-year risk strata for the
articipants included in this study, then after strat-
fication by sex and race. All analyses performed for
he current study (CARDIA year 15 examination;
ge range, 33 to 45 years) were also repeated in
econdary analyses using data from the CARDIA
ear 20 examination (age range, 38 to 50 years).
NS was defined as the number of people who
eed to be screened to identify 1 individual with a
AC score above the pre-specified CAC cut point
n each FRS category. It was calculated by dividing
he total number of participants by the number of
eople with a CAC score 0 (or 100) in each
RS stratum. The CAC amount was represented
y median CAC scores in FRS groups.
R E S U L T S
Baseline characteristics. Our study sample consisted
of a total of 2,832 black and white participants
(mean age, 40.3 years [range, 33 to 45 years]; 53%
women). With the exception of body mass index
and some measures of socioeconomic status, there
were significant differences in most of the tradi-
tional risk factors (including FRS) between those
with a CAC score of 0 versus a CAC score 0 and
a CAC score 100 versus a CAC score 100
(Table 1). Race and physical activity were significantly
different for the CAC score of 0 versus0 categories,
but not CAC score 100 versus 100 categories.
inety percent of individuals with a CAC score100
nd an FRS10% smoked, so that cigarette smoking
as the prevalent cardiovascular risk factor among this
ubset of our study population.
Of 1,501 women in our study, 76 had a CAC
core 0. Of these, 66 were premenopausal and 10
ere post-menopausal (data not shown). Among
re-menopausal women, 4.9% had the presence of
ny CAC versus 6.2% of postmenopausal women
p  0.45 for comparison of CAC prevalence
etween the 2 groups).
Distribution of CAC prevalence, amount, and NNS
compared across FRS strata. Table 2 shows the distri-
bution of CAC scores 0 and 100 across FRS
trata. Overall, CAC scores 0 and 100 were
resent in 9.9% and 1.8% of participants, respectively.
mong individuals with CAC, median CAC scores
ncreased with higher FRS. As expected, the preva-
ence of CAC scores 0 and 100 increased across
reater FRS strata (Fig. 1) (both p for trend 0.01).
onsequently, the NNS (signifying the number ofndividuals who need to be screened to detect 1 person
SBP  systolic blood pres
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926with a CAC score 0 [or 100]) decreased with a
higher FRS. In each CAC category, the NNS was
higher for lower than higher FRS strata (Table 2). For
example, among those with a CAC score of100, the
NNS was 79 for participants with an FRS of 0 to 2.5%
and 6 for those with an FRS 10%.
Table 2. CAC Prevalence, Amount, and NNS Compared With FR
CAC Score Group
0%–2.5%
(n  2,372)
2.6%–
(n  2
Median CAC score (IQR)* 17.9 (5.1–64.5) 16.6 (5.6–
CAC score 0, % (n  279) 7.3 20.2
NNS 13.7 5.0
CAC score 100, % (n  51) 1.3 2.4
NNS 79 41
*Among those with a CAC score 0.
IQR interquartile range, NNS number needed to screen (number of people
racteristics Stratiﬁed by CAC Score (N  2,832)
s
C
0 (n  2,553) >0 (n  279) p Va
40.1 3.6 42 3.1 0.0
56 27.2 0.0
45.8 34.4 0.0
112.4 14.1 118.5 16.1 0.0
74.1 11.1 78.1 12.6 0.0
l 183.8 34.3 198.4 40.6 0.0
51.1 14.3 46.1 14.3 0.0
112.3 30.6 127 37.8 0.0
19.3 32.3 0.0
t, % 6.0 11.1 0.0
1.7 4.7 0.0
attack, % 19.6 26.9 0.0
1.3 2.5 3.5 4.8 0.0
28.3 6.2 28.7 5.9 0.2
sity score) 352 282.8 403.4 310.8 0.0
0.0
ol 0.3 0.7
20.1 28
58 51.3
21.7 20.1
, % 54.3 50.9 0.2
0.3
14 16.3
24.2 27.1
23.2 20.2
38.7 36.5
87.8 85.7 0.3
%. Baseline refers to CARDIA year 15 examinations.
CAC  coronary artery calcium; DBP  diastolic blood pressure; FRS  Framing
sure.cut point in each Framingham risk score category); other abbreviations as in TableWhen data were stratified by sex, the general
pattern of distribution of CAC scores 0 and
100 across FRS strata remained the same, with a
higher prevalence of CAC scores 0 and 100
across FRS strata (Table 3). The prevalence of
CAC scores 0 and 100 was higher in men than
tegories (N  2,832)
FRS Categories
5.1%–10%
(n  115)
>10%
(n  58) p Value
) 18.9 (11.9–73.5) 58.8 (20.6–215.7)
19.1 44.8 0.01
5.2 2.2
3.5 17.2 0.01
28.8 5.8
need to be screened to identify 1 person with a CAC score above a pre-speciﬁed
Score Categories
<100 (n  2,781) >100 (n  51) p Value
40.2 3.6 43.1 2.6 0.01
53.6 27.5 0.01
44.9 33.3 0.10
112.9 14.3 120.8 18.4 0.01
74.4 11.2 81.4 14.7 0.01
185.0 34.9 199.6 50.6 0.01
50.7 14.3 45.9 15.8 0.02
113.5 31.4 125.4 43.9 0.01
20.2 39.2 0.01
6.4 11.8 0.12
1.8 11.8 0.01
19.9 45.1 0.01
1.4 2.7 5.2 6.9 0.01
28.3 6.2 28.2 6.3 0.88
357.0 285.6 365.6 314.3 0.83
0.14
0.3 2.0
20.7 27.5
57.4 52.9
21.6 17.7
54.0 52.9 0.89
0.29
14.0 21.6
24.6 15.7
22.9 21.6
38.4 41.2
87.7 86.3 0.77
Risk Score; HDL  high-density lipoprotein; LDL  low-density lipoprotein;S Ca
5%
87)
52.2
whoTable 1. Baseline Cha
Characteristic
AC
lue
Age, yrs 1
Female, % 1
Black race, % 1
SBP, mm Hg 1
DBP, mm Hg 1
Total cholesterol, mg/d 1
HDL, mg/dl 1
LDL, mg/dl 1
Current smoking, % 1
Hypertension treatmen 1
Lipid treatment, % 1
Family history of heart 1
FRS, % 1
BMI, kg/m2 8
Physical activity (inten 1
Education, % 1
Less than high scho
High school
College
Graduate school
Marital status: married 9
Income, % 8
$25,000
$25,000–$50,000
$50,000–$75,000
$75,000
Health insurance, % 0
Values are mean  SD or
BMI  body mass index; ham1.
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927women. Likewise, the overall median CAC scores
(among those with CAC) were higher in men.
Further stratification by race revealed that al-
though the overall prevalence of CAC was greater
in white compared with black participants, the overall
median CAC scores were higher in black than in
white participants (Table 4). As with the overall
distribution in Table 2, the prevalence of CAC scores
0 and 100 increased with higher FRSs.
The observed prevalence and NNS patterns were
imilar when CARDIA year 20 examination data
ere analyzed in the same fashion.
D I S C U S S I O N
We report the prevalence of CAC scores 0 and
100 relative to FRS strata in a cohort of young to
early middle-age black and white men and women
without diabetes. There was significant concor-
dance between CAC prevalence/amount and FRS
such that the prevalence of CAC scores 0 and
100 and median CAC scores were low in the
lower FRS strata and increased with higher FRSs.
Correspondingly, the NNS to detect CAC scores
0 or 100 was lower with higher FRSs. Findings
were similar when stratified by sex and race.
Potential implications. The FRS is a useful tool for
redicting coronary events, but fails to identify a
ignificant number of individuals who will have
vents (22,23). Clinical trial data showing reduced
vent rates due to CAC screening are lacking.
evertheless, recent data showed that compared
ith no CAC testing, randomization to CAC
creening was associated with improved coronary
rtery disease risk factor control without increased
ownstream medical testing (24). In addition,
AC predicts CHD events independent of the
RS (1,23) and appropriately reclassifies low-risk
Table 3. CAC Prevalence and Amount Compared With FRS Cate
CAC Score Group
0%–2.5%
(n  2,372)
2.6%
(n 
Males (n  1,327) n  927 n 
Median CAC score (IQR)* 20.6 (5.6–64.6) 16.6 (5
CAC score 0, % (n  203) 11.9 2
CAC score 100, % (n  37) 1.9
Females (n  1,505) n  1,445 n 
Median CAC score (IQR)* 15.0 (4.2–61.7) 19.1 (4
CAC score 0, % (n  76) 4.4 1
CAC score 100, % (n  14) 0.8
*Among those with a CAC score 0.
Abbreviations as in Table 2.ersons who will have events into the high-risk
ategory (2). In addition, CAC is useful for guiding
nd monitoring effects of therapy and for motivat-
ng patients in lifestyle and/or drug therapy for
ardiovascular risk factor modification (4). As such,
AC testing is a topic of discussion for different
onsensus panels.
In defining FRS thresholds for CAC screening,
xpert panels have generally focused on individuals
0 years of age and older and differ in their
ecommendations for what constitutes a reasonable
RS threshold at which to screen for CAC (1,3–6).
n the current study, we attempted to determine
RS thresholds at which screening for the presence
p for difference across strata for both CAC thresholds: < 0
CA
C 
Pr
ev
a
le
nc
e 
(%
)
Estimated 10-year FRS Categories
0
10
20
30
40
50
60
70
80
90
100
0 - 2.5% 2.6 - 5% 5.1 - 10% >10
Figure 1. CAC Score Compared With FRS
Prevalence of coronary artery calcium (CAC) scores 0 and 10
10-year Framingham Risk Score (FRS) strata in the CARDIA study
cant concordance between CAC prevalence/amount and FRS suc
CAC scores 0 and 100 were low in the lower FRS strata and
higher FRSs.
es, Stratiﬁed by Sex (N  2,832)
FRS Categories
%
7)
5.1%–10%
(n  115)
>10%
(n  58) p Value
1 n  106 n  53
1.8) 18.9 (10.8–76.5) 60.6 (20.6–215.7)
18.9 43.4 0.01
3.8 17.0
n  9 n  5
7.9) 30.6 (15.9–45.4) 33.0 (16.4–571.1)
22.2 60.0 0.01
0.0 20.0.01
CAC > 0
%
CAC ≥ 100
0 compared across
. There was signiﬁ-
h that prevalence of
increased withgori
–5
28
24
.6–4
0.8
2.5
46
.9–5
7.4
2.2
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928of CAC, and especially a high CAC burden, might
be useful in young to early middle-age individuals
based on distribution of CAC by FRS strata.
Compared with the presence of any CAC, a high
CAC burden (CAC score 100) has been associ-
ted with greater risk (2-fold and as high as a
-fold increase in multivariable-adjusted relative
isk) for CHD events (1,6,25,26). We therefore
ocus our discussion for the current study on deter-
ining possible FRS screening thresholds for CAC
cores 100.
We used the NNS as a tool to aid our prevalence
data in determining potential thresholds for CAC
screening across FRS strata. The NNS is an exten-
sion of the concept of the number needed to treat
and is typically defined as the number of people
who need to be screened to prevent 1 death or 1
adverse event (27). As in a previous study by our
group (8), we defined the NNS as the number of
people who need to be screened to detect 1 person
with CAC above a specified cut point in each FRS
stratum. The prevalence and NNS data from our
previous study (of multiethnic men and women 45
to 84 years of age) suggested a low yield of screen-
ing for clinically significant levels of CAC in
individuals with an FRS 5%.
In the current study, the prevalence of CAC
scores 100 was low (5%) among all FRS pre-
dicted strata 10%, and considerably higher (17%)
n those with an FRS 10%. Correspondingly, the
NS was much higher (NNS 28) in participants
ith an FRS of 0 to 2.5%, 2.6% to 5%, and 5.1% to
0% compared with those with an FRS 10%
NNS  6). Furthermore, the relative difference in
NS for CAC scores 100 was reasonably high
5-fold) for FRSs 10% versus 5.1% to 10%. This
elative difference for adjacent FRS strata was much
Table 4. CAC Prevalence and Amount Compared With FRS Cate
CAC Score Group
0%–2.5%
(n  2,372)
2.6%
(n 
White (n  1,566) n  1,307 n 
Median CAC score (IQR)* 16.5 (5.1–63.3) 22.4 (6
CAC score 0, % (n  183) 9.3 19
CAC score 100, % (n  34) 1.7 3
Black (n  1,266) n  1,065 n 
Median CAC score (IQR)* 34.6 (4.7–64.6) 13.2 (3
CAC score 0, % (n  96) 4.8 21
CAC score 100, % (n  17) 0.8 1
*Among those with a CAC score 0.
Abbreviations as in Table 2.ess (1.4-fold) for FRSs of 5.1% to 10% compared aith 2.6% to 5% and 2-fold for FRSs of 2.6% to
% versus 0 to 2.5%. Putting our findings in context,
t should be noted that in the MASS (Multicentre
neurysm Screening Study) (28), which used abdom-
nal ultrasound to evaluate the benefit of screening for
bdominal aortic aneurysms, the NNS to prevent 1
eath secondary to abdominal aortic aneurysm was
0.4 among those screened.
The prevalence and NNS data from our study
uggest a low yield of screening for CAC scores
100 in those young individuals identified as being
t lower 10-year risk of CHD events (FRSs10%).
hus, in this population, an FRS of 10% might
epresent a logical threshold for CAC screening in
ounger adults. This is in agreement with some
onsensus guidelines (1,3) that suggest that persons
t intermediate 10-year risk of CHD events (FRSs
f 10% to 20%) are more likely to benefit from
creening for CAC to aid further risk factor inter-
entions, especially in situations in which there is
ncertainty regarding the use of drug therapy.
ccording to the guidelines, those with an FRS
20% are considered to be at high risk of CHD
vents and should be appropriately managed with
rug therapy and lifestyle modifications (17). Also
n support of expert panels (1,6), our study suggests
hat decisions regarding CAC measurement should
e made in the context of traditional cardiovascular
isk factors rather than in isolation. As such, data
rom our study support the avoidance of radiation
xposure, discovery of incidental findings requiring
ollow-up computed tomography scans, as well as
ime, money, and effort spent on CAC measure-
ent for clinical guidance in young, low-risk pa-
ients with an FRS 10%.
Other ﬁndings. Consistent with other studies, strat-
fication by sex and race revealed the prevalence and
es, Stratiﬁed by Race (N  2,832)
FRS Categories
)
5.1%–10%
(n  115)
>10%
(n  58) p Value
n  64 n  36
3.5) 16.8 (9.8–31.8) 24.1 (10.0–161.2)
20.3 47.2 0.01
1.6 16.7
n  51 n  22
0.0) 45.4 (12.5–108.2) 76.9 (36.3–215.7)
17.7 40.9 0.01
5.9 18.2gori
–5%
287
159
.6–5
.5
.1
128
.7–3
.1
.6mount of CAC to be higher in men than in
L
B
s
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929women and CAC prevalence to be higher in whites
compared with blacks (29–33). Contrary to expec-
tations, however, median CAC scores were higher
in black than in white participants, likely due to the
skewed distribution of data as a result of fewer
participants in the higher FRS categories. Because
of the young age of the cohort, we did not stratify
our data by age. Not surprisingly in this young
cohort, cigarette smoking was the most predomi-
nant risk factor among those with CAC scores of
100 and FRSs 10%. This represents individuals
already at higher risk of CHD/cardiovascular dis-
ease events based on FRS for whom smoking
cessation should be emphasized as a modifiable risk
factor, especially if CAC screening revealed signif-
icant CAC burden.
Study limitations. The very low number of CHD
events in this young cohort to date precluded
validation of our suggested FRS cut points for CAC
screening using event data. Furthermore, due to the
relative youth of our cohort, we had few participants
with high CAC burden. As such, we used a lower
cut point for high CAC burden (CAC score 100)
and could not examine NNS and FRS distributions
relative to advanced CAC burden (CAC scores
300 or 400). Our study, however, is likely repre-from the American Heart Association Cao F, Brazaitis MU.S. young adults. For the same reason, there were
fewer participants with a CAC score of 100 in
each FRS category when stratified by sex and race.
Finally, we did not separate the intermediate FRS
(10% to 20%) from the high FRS (20%) risk
groups because, of 58 individuals with an FRS
10% in this young cohort, only 6 persons had an
FRS 20% (3 of whom had the presence of any
CAC).
C O N C L U S I O N S
In this young to early middle-age nondiabetic,
asymptomatic cohort, there was concordance be-
tween CAC prevalence/amount and FRS strata.
Our study suggests that in this group of relatively
young individuals, the yield of screening for high
CAC burden (CAC score 100) among low-risk
persons with an FRS of 10% is low. However,
CAC testing might be considered in younger per-
sons with an FRS of 10%.
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